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Introduction 46
Hand, foot and mouth disease (HFMD) is a febrile illness that predominantly affects infants and young children, and is characterized by rash and blisters on the hands, In this study, clinical EV71 isolates associated with differing levels of severity 71 (mild, moderate, and severe) collected from an outbreak in 2006 in Sarawak, Malaysia 72 (19) , were used to characterize and compare the infection kinetics, virus tropism and 73 immuno-pathogenesis using in vitro and ex vivo models. In particular, infection kinetics 74 and high-density transcriptomic profiling by RNA-sequencing (RNA-seq) of EV71-75 infected peripheral blood mononuclear cells (PBMCs) revealed several virus severity-76 dependent differences. Collectively, this is the first report describing the immune 77 mechanisms involved during EV71 infections in primary human cells, and the 78 identification of novel pathways, such as triggering receptor expressed on myeloid 79 cells 1 (TREM-1) signaling, that are unique and specific to the severe EV71 isolate, 80 and likely contributing to the severe manifestations of the disease. 81
Results 82
Clinical EV71 isolates are phylogenetically classified based on disease 83 outcomes 84
Six EV71 isolates were identified from patients during an outbreak of HFMD in 85 Sarawak, Malaysia, in 2006 (20) . These patients had differing levels of disease 86 severity, ranging from mild herpangina/HFMD, severe HFMD in the absence or 87 presence of neurological complications, and one fatality ( Figure 1A ). However, 88 alignment analysis of the different coding sequences of the virus revealed the isolates 89 to be at least 92% identical to one another (Table S1 ). Moreover, phylogenetic 90 classification of the viruses based on the sequence of the VP1 gene identified them 91 as belonging to the B5 sub-genogroup, and were closely related to strains circulating 92 in Sarawak, Brunei, and Singapore from 2003 to 2008 ( Figure S1 ). Despite sharing 93 96% VP1 genetic similarity (Table S1 ), all of the isolates, except isolate 3, were 94 observed to be clustered according to disease severity in the phylogenetic tree (Figure 95 S1). 96 97
Severe EV71 isolate infects human muscle RD cells to high levels 98
To investigate if the different EV71 clinical isolates have a different infection profile 99 that could contribute to disease outcome, infection kinetics were compared in human 100 muscle rhabdomyosarcoma (RD) cells and neuroblastoma SH-SY5Y cells at 101 multiplicity of infections (MOI) 10 and 1, respectively. These cell lines have been 102 extensively used in elucidating viral kinetics (7, 21) and pathogenesis of enteroviruses 103 (22, 23) . The infection kinetics across a time-course of 0, 3, 6, 12, and 24 hours post-104 infection (hpi) were determined by measuring infectivity parameters of percentage of 105 intracellular VP1 antigen-positive cells by flow cytometry ( Figure S2A ) and levels of 106 VP1 RNA load by qRT-PCR. In RD cells, the percentage of infected VP1+ cells among 107 the EV71 isolates 1, 2 and 3 within the mild disease phenotype group were similar by 108 24 hpi ( Figure S2B ). Likewise, there were no significant differences between isolates 109 5 and 6 of the severe phenotype over the course of the time-points ( Figure S2C ). As 110 such, isolates 1, 4 and 5 were chosen as representatives for further characterization, 111 and were defined as "mild", "moderate", and "severe" EV71 isolates respectively. 112
The severe isolate showed the highest level of infection in RD cells, followed 113 by moderate and mild ( Figures 1B and 1C ). The percentage of EV71 VP1 antigen in 114 live cells assessed via flow cytometry showed that by 24 hpi, severe EV71-infected 115 RD cells exhibited the highest levels of VP1+ cells, followed closely by moderate 116 EV71, and mild EV71 ( Figure 1B ). Severe EV71 also showed significantly higher virus 117 replication compared to the mild isolate from 3 to 24 hpi, whereas moderate EV71 had 118 higher VP1 RNA copies than mild EV71 only at 24 hpi ( Figure 1C ). However, there 119 were no significant differences in percentage of VP1+ cells and viral RNA copies 120 among the three isolates at almost all time-points in SH-SY5Y cells (Figures 1D and 121 1E) . 122 123
Primary human monocytes, B and T cells are the main targets of EV71 124
Infection kinetics of the different EV71 isolates were next explored in human PBMCs 125 to assess if the associated disease severity affects the ability of the virus to infect the 126 primary cells, which are more biologically relevant than cell lines. In this ex vivo model, 127 healthy donor PBMCs were infected with mild, moderate, severe, and heat-inactivated 128 forms of EV71 at MOI 5 over 0, 6, 12 and 24 hpi. PBMCs infected with moderate and 129 severe isolates of EV71 had higher levels of viral VP1 RNA load compared to the mild 130 isolate (Figure 2A ). The latter showed lower and limited viral replication throughout the 131 course of infection, whereas moderate EV71-infected PBMCs had the highest viral 132 load in the initial phase, before steadily decreasing over time ( Figure 2A ). However, 133
PBMCs infected with the severe isolate demonstrated increasing viral load levels till 134 12 hpi, before dropping off at 24 hpi (Figure 2A ). These observed trends were also 135 consistent with the percentage of EV71 VP1 antigen detected from total CD45+ 136 leukocytes ( Figures 2B and 2C) . 137
To identify the specific subsets susceptible to EV71 infection, cells were further 138 gated into the different populations: T cells, B cells, monocytes, and natural killer (NK) 139 cells ( Figure S2D ). T and B lymphocytes, as well as monocytes, were the main 140 susceptible subsets within the PBMCs ( Figures 2B and 2C ). In contrast, NK cells 141 showed limited and lower levels of infectivity ( Figure S2E ). Again, PBMCs infected 142 with mild EV71 demonstrated an overall limited percentage of VP1 antigen within the 143 three susceptible subsets ( Figure 2B ), whereas moderate-infected PBMCs showed 144 highest VP1 percentage in B cells, followed closely by monocytes, and T cells ( Figure  145 2B). On the other hand, PBMCs infected with the severe isolate displayed a slightly 146 different trend, with the highest percentage of VP1 antigen observed in the monocytes, 147 followed by B cells and T cells ( Figure 2B ). Moreover, there was an increase in the 148 percentage of VP1 antigen in the B and T lymphocytes populations at 6 hpi and 12 hpi 149 respectively, whereas in the monocytes the percentage decreased at 6 hpi but was 150 sustained throughout the course of infection ( Figure 2B ). 151 152
Transcriptomic profiling reveals a strong induction of host antiviral immune 153 response upon EV71 infection 154
To identify the possible mediators responsible for the disease severity-dependent 155 differences, RNA-seq was performed on samples of EV71-infected PBMCs from four 156 donors to identify and quantitate mRNA abundance and changes throughout the 157 course of infection at 0, 6, 12 and 24 hpi. Mapped genes of infected conditions were 158 normalized to a heat-inactivated control virus at the respective time-points. The results 159 showed that the number of significant differentially expressed transcripts (false 160 discovery rate [FDR] < 0.05) were different across time-points as well as isolates 161 ( Figure 3A ). During the course of infection, the greatest change occurred from 0 to 6 162 hpi for all EV71 isolates, as indicated by the sharp increase in the number of 163 differentially expressed genes (DEGs), and the amount of DEGs continued to show 164 an overall increasing trend from 6 to 24 hpi ( Figure 3A ). Strikingly, moderate EV71 165 demonstrated the highest numbers of DEGs throughout infection, followed by severe 166 EV71, and mild EV71 ( Figure 3A) . 167
Significant DEGs of the respective isolates and time-points were analyzed in 168
Ingenuity Pathway Analysis (IPA) to identify functional pathways ( Figure 3B ). The 169 numbers of significantly enriched canonical pathways [-log(p-value) > 1.30] were 170 highest for severe EV71-infected PBMCs, especially from 6 to 24 hpi ( Figure 3B ), 171 despite being presented with fewer differentially expressed transcripts than moderate-172 infected PBMCs ( Figure 3A ). PBMCs infected with mild EV71 displayed the lowest 173 number of functional pathways ( Figure 3B ). 174
In order to characterize the cellular responses elicited upon EV71 infection, 175 transcripts that were common among the three isolates at time-points 6 to 24 hpi were 176 identified and further analyzed. Regardless of isolate severity, a total of 36 genes were 177 differentially expressed during EV71 infection (Table S2) , and these genes are known 178 to be involved in the antiviral interferon response, inflammatory processes, as well as 179 in apoptosis ( Figure 3C ). Nonetheless, the proportion of fold change for most of the 180 genes differed across time and among the EV71 isolates. Notably, PBMCs infected 181 with moderate EV71 showed a stronger response than the mild and severe isolates, 182 specifically interferon-stimulated gene 15 (ISG15), viperin (RSAD2), ubiquitin specific 183 peptidase 18 (USP18), interferon alpha inducible protein 27 (IFI27), and guanosine 184 monophosphate reductase (GMPR) ( Figure 3C ). Next, in order to identify the common 185 functional pathways, the 36 genes were further analyzed in IPA. The results yielded 186 12 significant canonical pathways (Table S3) was most significantly activated in severe EV71-infected conditions at 6 hpi that 192 persisted till 24 hpi ( Figure 3E ). However, a different pattern was observed for mild 193 and moderate EV71 infections, in which the activation of this pathway became less 194 pronounced over time ( Figure 3E ). Similar observations were also seen for the 195 interferon-regulatory factor (IRF) activation pathway ( Figure 3E ). 196 197
Activation of TREM-1 pathway is specific to severe EV71 infection 198
Given that the different EV71 isolates belonged to the same sub-genotype B5 (Figure 199 S1), and yet were able to give rise to such varied clinical outcomes in patients ( Figure  200 1A), we then sought to understand this by identifying and comparing the unique DEGs 201 of the EV71 isolates at the respective time-points of 6, 12 and 24 hpi. The three 202 isolates showed distinctive trends ( Figure 4A ). While the number of unique genes 203 increased slightly from 6 to 13 DEGs (6 to 24 hpi) in the mild-infected condition, the 204 moderate EV71-infected PBMCs displayed an opposite trend, with a decrease in the 205 numbers from 42 to 20 DEGs ( Figure 4A ). On the other hand, infection of PBMCs with 206 severe EV71 isolate showed an increasing number of DEGs specific to this isolate (4 207 to 16 DEGs at 6 and 24 hpi) ( Figure 4A ). Examples of enriched DEGs distinct to each 208 isolate were nuclear protein 1 (NUPR1) for mild, chemokine (C-X-C motif) ligand 13 209 (CXCL13) for moderate, and interleukin-6 (IL-6) for severe EV71 infections (Table S4) . 210
An analysis of the unique DEGs with IPA revealed significant canonical pathways 211 similar to the observations as in Figure 4A ( Figure 4B ). 212
Since the numbers of activated canonical pathways in EV71-infected PBMCs 213
were the highest at 24 hpi ( Figures 3B and 4B ), the differential genes of each isolate 214 at this particular time-point were input into IPA and comparison analyses were carried 215 out ( Table S4 ). The top 10 canonical pathways, based on the activation z-scores as 216 determined by IPA, were selected for further analysis ( Figure 4C and Table S5 ). 217
Remarkably, PBMCs infected with severe EV71 showed a very distinctive response. 218
Pathways such as IL-6, neuro-inflammation, role of IL-17F in allergic inflammatory 219 airway diseases, and TREM-1 signaling processes were significantly and highly 220 activated but were absent or lacking in the mild and moderate EV71-infected 221 conditions ( Figure 4C ). Notably, the TREM-1 signaling pathway was most distinctive 222 in severe EV71 infection ( Figure 4C ). The expression of genes involved in this pathway 223 were strongly enriched for CXCL3, IL-1b and IL-6 in the severe-infected condition 224 ( Figure 4D ). Moreover, TREM-1 pathway had not been explored before in the context 225 of EV71 infection, and as such, this pathway was further studied in subsequent 226
experiments. 227 228

Reduced TREM-1 expression mitigates EV71 infection 229
To verify the role of TREM-1 signaling pathway as an important mediator in EV71 230 infection, a series of blocking experiments were carried out in which healthy donor 231 PBMCs were pre-treated with 100 ng/ml of synthetic peptide LP17 ( Figure S3A ). LP17 232 was previously shown to be able to compete with the ligand and block the TREM-1 233 receptor, thus inhibiting inflammatory responses (24-26). A scrambled form of the 234 peptide, named sLP17, was used as negative control ( Figure S3A ). PBMCs were then 235 infected with mild, moderate and severe EV71 isolates at MOI 5, as well as mock-236 infected, before fresh media containing the final concentration of peptides were added 237 ( Figure S3A ). In addition, as positive controls, PBMCs were subjected to 238 lipopolysaccharide (LPS) treatment in the presence of peptides. To validate that the 239 blocking was efficient, total RNA samples of peptide-and LPS-treated PBMCs were 240 subjected to gene expression studies by qRT-PCR ( Figure S3B Similarly, in the EV71-infected conditions, a reduced gene expression profile 245 was observed for the moderate and severe EV71 isolates ( Figure 5A ). However, the 246 intensity of TREM-1 inhibition was more pronounced in moderate isolate infection 247 when compared to severe-infected condition ( Figure 5A ). On the other hand, mild 248 EV71 showed minimal changes in the relative level of gene expression, suggesting 249 that TREM-1 activation in this isolate could be too low to detect for any inhibition 250 ( Figure 5A ). The impact of EV71 viral replication upon TREM-1 inhibition was then 251 assessed by qRT-PCR. Consistent with the minor effects observed in the gene 252 expression results, infection with mild EV71 showed no differences in the number of 253 viral VP1 RNA copies under the blocked and control states ( Figure 5B ). However, 254 treatment with LP17 to inhibit TREM-1 resulted in a lower viral VP1 RNA load in both 255 the moderate and severe EV71 infections ( Figure 5B ). 256
Discussion 257
Patients suffering from EV71 infections can present different clinical manifestations 258 and severity. Previous studies have suggested that outcomes of EV71 infections could 259 be influenced by the genetic makeup of the virus, as well as the immune status of the 260 patient (19, 27-30). Alignment of the various genes of the isolates revealed that non-261 structural gene 3A was highly dissimilar between the moderate and mild isolates (92% 262 identity) (Table S1 ). The 3A protein has been shown to be important for virus RNA 263 replication, with its involvement in the formation of replication organelles (31-33). It 264 was recently reported that recruitment of phosphatidylinositol 4-kinase IIIb (PI4KB) by 265 the interaction of host factor acyl-CoA binding domain containing 3 (ACBD3) and EV71 266
3A facilitated viral replication (34), thus suggesting that perhaps certain nucleotide 267 differences in the moderate isolate could lead to its increased virulence. Nonetheless, 268 all EV71 isolates were highly genetically identical overall (at least 96%). Yet, viral 269 severity-dependent effects were observed in muscle RD cells and in PBMCs. 270
Moderate and severe EV71 isolates demonstrated high levels of infection and 271 replication, while mild EV71 showed lower infectivity. However in neuronal SH-SY5Y 272 cells, mild and moderate EV71 exhibited similar levels of replication kinetics as the 273 severe isolate, suggesting that the mild and moderate isolates could potentially cause 274 neuro-pathogenesis if the blood-brain barrier permeability is compromised. The results 275 support the importance of the virus' genetic component in determining virulence and 276 in shaping clinical outcomes in patients. 277
Intriguingly, between the moderate and severe EV71 infections in PBMCs, the 278 latter exhibited a steady increase in infection and replication over time while the former 279 showed a strong infection only in the initial phase. This was also supported in the 280 transcriptomic results, in which the viral recognition pathway by PRR remained 281 activated specifically for severe EV71, thus emphasizing the ongoing replication of 282 virus over time. In addition, several pathways such as neuro-inflammation and IL-6 283 signaling were identified to be strongly associated or unique to severe EV71 infection. 284
Cytokines IL-1b and IL-6 are the common denominators of these pathways and are 285 therefore likely to play a role in the severe pathogenesis of EV71. In earlier reports, 286 levels of IL-1b, IL-6 and TNFa were found to be significantly elevated in fatal EV71 287 patients with encephalitis and pulmonary edema, when compared to patients with no 288 complications (29, 35-37). Production of such inflammatory cytokines are mediated 289 by monocytes, macrophages, as well as T and B lymphocytes (37), and in agreement 290 with this, these immune cells were the subsets shown to be the most susceptible to 291 EV71 in this study and elsewhere (38) (39) (40) . 292
The link between pro-inflammatory response and severe EV71 outcome is also 293 further strengthened with the identification of TREM-1 activation, which is unique and 294 distinct to the severe isolate. TREM-1 is a cell surface receptor that is highly expressed 295 on monocytes and neutrophils, and is known as a critical player in the amplification of 296 inflammation via the production of pro-inflammatory mediators (41). TREM-1 can also 297 exist as a soluble variant, with its expression levels indirectly proportional to that of its 298 receptor form (41). To date, TREM-1 modulation in viral infections has been described 299 for dengue, Marburg (MARV) and Ebola (EBOV) viruses among others (26, 42). In 300 dengue-infected patients, the expression of TREM-1 on neutrophils was significantly 301 reduced in the acute phase of the disease, with high levels of soluble TREM-1 in sera 302 (42). On the other hand, MARV and EBOV were able to activate TREM-1 on human 303 neutrophils in vitro, and the blocking of TREM-1 receptor by LP17 peptide treatment 304 resulted in diminished production of TNFa and IL-1b (26). Although a decrease in the 305 expression of pro-inflammatory mediators was also observed in this study, the effect 306 of the treatment was most significant for the moderate isolate of EV71. Moreover, 307 although a lower viral load was observed in the blocked conditions of moderate and 308 severe infections, results were not significant when compared to the control condition. 309 Therefore, inhibition of TREM-1 specifically targeted the downstream immune 310 response after virus infection. Previously, TREM-1-deficient mice infected with either 311
Leishmania major, influenza virus or Legionella pneumophila were able to 312 demonstrate reduced morbidity and immune-associated pathologies, with minimal 313 effect on pathogen clearance (43). Another plausible explanation could be attributed 314 to the host genetic factors, as donor-to-donor variations were observed in our study. 315
Gene polymorphisms within TREM-1 have been linked to the development of 316 inflammation and sepsis (44), and it has been reported that there is a positive 317 association between patients carrying the TREM-1 rs2234237T allele and the 318 development of severe malaria, due to the presence of higher levels of soluble TREM-319 1 in the plasma of these patients (45). Given that polymorphisms in EV71 receptors, 320 scavenger receptor class B member 2 (SCARB2) and P-selectin glycoprotein ligand-321 1 (PSGL-1), have been shown to affect EV71 susceptibility and infection respectively 322 (46), genomic variations within TREM-1 could also therefore play a role in modulating 323 EV71 infection and outcomes. 324
In conclusion, this study characterized and compared the cellular responses 325 elicited by EV71 isolates of differing clinical severity and revealed the novel 326 involvement of TREM-1 in the pathogenesis of severe EV71. Importantly, TREM-1 327 expression levels could serve as a prognostic marker for severe EV71 infections in 328 patients, and might point the way towards future therapies. 329
Materials and Methods 330
Ethics approval 331
Human blood apheresis cones were obtained from healthy volunteers with written 332 O'nyong'nyong virus (ONNV). Analytical sensitivity was also determined using 415 quantitated EV71 RNA transcripts. The lower limit of detection was estimated as 10 416 copies for the VP1 gene target. Copy numbers of EV71 RNA were determined using 417 the Ribogreen RNA-specific Quantitation Kit (Invitrogen). RNA transcripts from 10 to 418 10 9 copies were performed in pentaplicates to construct a standard curve to estimate 419 EV71 copy number in samples. 420 Table  451 S6. 452
453
RNA-seq and differential gene expression analysis 454
The methods for RNA-seq and differential expression were previously described (57-455 59) and are briefly described below. Interferon Signaling 
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